Lactobacillus salivarius, a Potential Probiotic to Improve the Health of LPS-Challenged Piglet Intestine by Alleviating Inflammation as Well as Oxidative Stress in a Dose-Dependent Manner During Weaning Transition
- 2020-12-16
- Frontiers in Veterinary Science 7
- Zeyang Sun
- Haihua Li
- Yupeng Li
- J. Qiao
- PubMed: 33392276
- DOI: 10.3389/fvets.2020.547425
Abstract
Intestinal health is a critical issue for piglets during their weaning transition period. Previous reports have emphasized the promise of distinct probiotics in improving the enteric health. Here in this research, a newly isolated Lactobacillus salivarius strain was pretreated to Lipopolysaccharide (LPS)-challenged piglets and its association with integrity of the intestinal barrier coupled with effective dosage were expected to be signified. In the present study, 72 piglets (Landrace × Yorkshiere × Duroc) were randomly allotted to four groups, each group with six replicates. The subjects in the control group were provided with basal diet while those in other tested groups with extra 0.05, 0.1, and 0.2% L. salivarius, respectively. Fourteen days later, LPS was intraperitoneally injected and sodium pentobarbital was then delivered to euthanize those LPS-challenged piglets. An increase of average daily gain and body weight along with an apparent decline of diarrhea rate were observed in L. salivarius-treated groups. Both 0.1 and 0.2% L. salivarius supplement in total diet had the capability to markedly elevate levels of CAT, GSH-Px, SOD, anti-inflammatory cytokine from the serum as well as tight junction proteins (Claudin-1, Occludin, and ZO-1) extracted from intestine in LPS-challenged piglets. These changes were accompanied by the obvious downregulation of D-lactic acid, DAO, MDA and pro-inflammatory mediators in the serum, including IL-1β, IL-6, IFN-γ, and TNF-α. Meanwhile, the expression levels of TLR2 and TLR4 in spleen and mesenteric lymph nodes were significantly lower whereas the oxidation-related gene, ho-1 was up-regulated with L. salivarius administration. Our findings suggested that relatively high dose L. salivarius (0.1-0.2%) could regulate the progression of inflammatory response and oxidative stress when individuals were exposed to LPS, thus probably offering valuable assistance in restoring barrier function and improving overall performance.
Keywords: L. salivarius; LPS; inflammatory response; oxidative stress; post-weaned piglets.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus Salivarius | Increased Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus Salivarius | Increased Intestinal Tight Junction Protein Expression | Beneficial | Large |
Lactobacillus Salivarius | Increased Serum Anti-inflammatory Cytokines | Beneficial | Moderate |
Lactobacillus salivarius BLIS K12 | Increased Anti-Inflammatory Cytokine Levels | Beneficial | Large |
Lactobacillus salivarius BLIS K12 | Increased Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus salivarius BLIS K12 | Increased Expression of Oxidation-related Gene HO-1 | Beneficial | Large |
Lactobacillus salivarius BLIS K12 | Increased Tight Junction Proteins (Claudin-1) | Beneficial | Large |
Lactobacillus salivarius BLIS K12 | Reduced Diarrhea Rate | Beneficial | Moderate |
Lactobacillus salivarius BLIS K12 | Reduced Pro-Inflammatory Cytokines | Beneficial | Large |
Lactobacillus salivarius CRL 1328 | Enhanced Antioxidant Activity | Beneficial | Large |
Lactobacillus salivarius CRL 1328 | Improved Growth Performance | Beneficial | Moderate |
Lactobacillus salivarius CRL 1328 | Improved Intestinal Barrier Function | Beneficial | Large |
Lactobacillus salivarius CRL 1328 | Reduced Inflammatory Response | Beneficial | Large |
Lactobacillus salivarius CRL 1328 | Regulated Oxidative Stress | Beneficial | Moderate |
Lactobacillus salivarius HA-118 | Increased Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus salivarius HA-118 | Reduced Diarrhea Rate | Beneficial | Moderate |
Lactobacillus salivarius SD-5208 | Improved Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus salivarius SD-5208 | Increased Expression of Oxidation-related Gene HO-1 | Beneficial | Large |
Lactobacillus salivarius SD-5208 | Increased Tight Junction Protein Levels | Beneficial | Large |
Lactobacillus salivarius SD-5208 | Reduced Diarrhea Incidence | Beneficial | Large |
Lactobacillus salivarius SD-5208 | Reduced Proinflammatory Mediators | Beneficial | Large |
Lactobacillus salivarius SD-5851 | Increased Anti-Inflammatory Cytokine Levels | Beneficial | Large |
Lactobacillus salivarius SD-5851 | Increased Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus salivarius SD-5851 | Increased Expression of Oxidation-related Gene HO-1 | Beneficial | Large |
Lactobacillus salivarius SD-5851 | Increased Tight Junction Proteins (Claudin-1) | Beneficial | Large |
Lactobacillus salivarius SD-5851 | Reduced Diarrhea Incidence | Beneficial | Large |
Lactobacillus salivarius SD-5851 | Reduced Levels of Pro-Inflammatory Cytokines (IL-1β, IL-6, IFN-γ, TNF-α) | Beneficial | Large |
Lactobacillus salivarius SD-5851 | Reduced Serum D-Lactate Levels | Beneficial | Large |
Lactobacillus salivarius UALb-07 | Increased Anti-inflammatory Cytokines | Beneficial | Large |
Lactobacillus salivarius UALb-07 | Increased Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus salivarius UALb-07 | Increased Tight Junction Proteins (Claudin-1) | Beneficial | Large |
Lactobacillus salivarius UALb-07 | Reduced Diarrhea Incidence | Beneficial | Large |
Lactobacillus salivarius UALb-07 | Reduced Proinflammatory Mediators | Beneficial | Large |
Lactobacillus salivarius UALs07 | Improved Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus salivarius UALs07 | Improved Tight Junction Protein Expression | Beneficial | Moderate |
Lactobacillus salivarius UALs07 | Increased Expression of Oxidation-related Gene HO-1 | Beneficial | Large |
Lactobacillus salivarius UALs07 | Reduced Diarrhea Rate | Beneficial | Moderate |
Lactobacillus salivarius UALs07 | Reduced Pro-inflammatory Mediator Levels | Beneficial | Large |
Lactobacillus salivarius UALs07 UAS | Improved Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus salivarius UALs07 UAS | Increased Expression of Oxidation-Related Gene | Beneficial | Moderate |
Lactobacillus salivarius UALs07 UAS | Increased Tight Junction Protein Levels | Beneficial | Large |
Lactobacillus salivarius UALs07 UAS | Reduced Pro-Inflammatory Mediator Production | Beneficial | Large |
Lactobacillus salivarius UCC118 | Improved Intestinal Barrier Function | Beneficial | Large |
Lactobacillus salivarius UCC118 | Increased Antioxidant Enzyme Levels | Beneficial | Large |
Lactobacillus salivarius UCC118 | Reduced Diarrhea Rate | Beneficial | Moderate |
Lactobacillus salivarius UCC118 | Reduced Interleukin-6 Levels | Beneficial | Large |
Lactobacillus salivarius UCC118 | Regulated Immune Response | Beneficial | Large |
Lactobacillus salivarius VPro 15 | Increased Anti-inflammatory Cytokines | Beneficial | Large |
Lactobacillus salivarius VPro 15 | Increased Expression of Oxidation-related Gene HO-1 | Beneficial | Large |